Devices for Inhaled Medications Market
1 Study Coverage
1.1 Devices for Inhaled Medications Product Introduction
1.2 Market by Type
1.2.1 Global Devices for Inhaled Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dry Powder Inhalers
1.2.3 Metered-Dose Inhalers
1.2.4 Nebulizers
1.2.5 Soft Mist Inhaler
1.3 Market by Application
1.3.1 Global Devices for Inhaled Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Devices for Inhaled Medications Sales Estimates and Forecasts 2017-2028
2.2 Global Devices for Inhaled Medications Revenue Estimates and Forecasts 2017-2028
2.3 Global Devices for Inhaled Medications Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Devices for Inhaled Medications Sales by Region
2.4.1 Global Devices for Inhaled Medications Sales by Region (2017-2022)
2.4.2 Global Sales Devices for Inhaled Medications by Region (2023-2028)
2.5 Global Devices for Inhaled Medications Revenue by Region
2.5.1 Global Devices for Inhaled Medications Revenue by Region (2017-2022)
2.5.2 Global Devices for Inhaled Medications Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Devices for Inhaled Medications Sales by Manufacturers
3.1.1 Global Top Devices for Inhaled Medications Manufacturers by Sales (2017-2022)
3.1.2 Global Devices for Inhaled Medications Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Devices for Inhaled Medications in 2021
3.2 Global Devices for Inhaled Medications Revenue by Manufacturers
3.2.1 Global Devices for Inhaled Medications Revenue by Manufacturers (2017-2022)
3.2.2 Global Devices for Inhaled Medications Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Devices for Inhaled Medications Revenue in 2021
3.3 Global Devices for Inhaled Medications Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Devices for Inhaled Medications Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Devices for Inhaled Medications Sales by Type
4.1.1 Global Devices for Inhaled Medications Historical Sales by Type (2017-2022)
4.1.2 Global Devices for Inhaled Medications Forecasted Sales by Type (2023-2028)
4.1.3 Global Devices for Inhaled Medications Sales Market Share by Type (2017-2028)
4.2 Global Devices for Inhaled Medications Revenue by Type
4.2.1 Global Devices for Inhaled Medications Historical Revenue by Type (2017-2022)
4.2.2 Global Devices for Inhaled Medications Forecasted Revenue by Type (2023-2028)
4.2.3 Global Devices for Inhaled Medications Revenue Market Share by Type (2017-2028)
4.3 Global Devices for Inhaled Medications Price by Type
4.3.1 Global Devices for Inhaled Medications Price by Type (2017-2022)
4.3.2 Global Devices for Inhaled Medications Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Devices for Inhaled Medications Sales by Application
5.1.1 Global Devices for Inhaled Medications Historical Sales by Application (2017-2022)
5.1.2 Global Devices for Inhaled Medications Forecasted Sales by Application (2023-2028)
5.1.3 Global Devices for Inhaled Medications Sales Market Share by Application (2017-2028)
5.2 Global Devices for Inhaled Medications Revenue by Application
5.2.1 Global Devices for Inhaled Medications Historical Revenue by Application (2017-2022)
5.2.2 Global Devices for Inhaled Medications Forecasted Revenue by Application (2023-2028)
5.2.3 Global Devices for Inhaled Medications Revenue Market Share by Application (2017-2028)
5.3 Global Devices for Inhaled Medications Price by Application
5.3.1 Global Devices for Inhaled Medications Price by Application (2017-2022)
5.3.2 Global Devices for Inhaled Medications Price Forecast by Application (2023-2028)
6 North America
6.1 North America Devices for Inhaled Medications Market Size by Type
6.1.1 North America Devices for Inhaled Medications Sales by Type (2017-2028)
6.1.2 North America Devices for Inhaled Medications Revenue by Type (2017-2028)
6.2 North America Devices for Inhaled Medications Market Size by Application
6.2.1 North America Devices for Inhaled Medications Sales by Application (2017-2028)
6.2.2 North America Devices for Inhaled Medications Revenue by Application (2017-2028)
6.3 North America Devices for Inhaled Medications Market Size by Country
6.3.1 North America Devices for Inhaled Medications Sales by Country (2017-2028)
6.3.2 North America Devices for Inhaled Medications Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Devices for Inhaled Medications Market Size by Type
7.1.1 Europe Devices for Inhaled Medications Sales by Type (2017-2028)
7.1.2 Europe Devices for Inhaled Medications Revenue by Type (2017-2028)
7.2 Europe Devices for Inhaled Medications Market Size by Application
7.2.1 Europe Devices for Inhaled Medications Sales by Application (2017-2028)
7.2.2 Europe Devices for Inhaled Medications Revenue by Application (2017-2028)
7.3 Europe Devices for Inhaled Medications Market Size by Country
7.3.1 Europe Devices for Inhaled Medications Sales by Country (2017-2028)
7.3.2 Europe Devices for Inhaled Medications Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Devices for Inhaled Medications Market Size by Type
8.1.1 Asia Pacific Devices for Inhaled Medications Sales by Type (2017-2028)
8.1.2 Asia Pacific Devices for Inhaled Medications Revenue by Type (2017-2028)
8.2 Asia Pacific Devices for Inhaled Medications Market Size by Application
8.2.1 Asia Pacific Devices for Inhaled Medications Sales by Application (2017-2028)
8.2.2 Asia Pacific Devices for Inhaled Medications Revenue by Application (2017-2028)
8.3 Asia Pacific Devices for Inhaled Medications Market Size by Region
8.3.1 Asia Pacific Devices for Inhaled Medications Sales by Region (2017-2028)
8.3.2 Asia Pacific Devices for Inhaled Medications Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Devices for Inhaled Medications Market Size by Type
9.1.1 Latin America Devices for Inhaled Medications Sales by Type (2017-2028)
9.1.2 Latin America Devices for Inhaled Medications Revenue by Type (2017-2028)
9.2 Latin America Devices for Inhaled Medications Market Size by Application
9.2.1 Latin America Devices for Inhaled Medications Sales by Application (2017-2028)
9.2.2 Latin America Devices for Inhaled Medications Revenue by Application (2017-2028)
9.3 Latin America Devices for Inhaled Medications Market Size by Country
9.3.1 Latin America Devices for Inhaled Medications Sales by Country (2017-2028)
9.3.2 Latin America Devices for Inhaled Medications Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Devices for Inhaled Medications Market Size by Type
10.1.1 Middle East and Africa Devices for Inhaled Medications Sales by Type (2017-2028)
10.1.2 Middle East and Africa Devices for Inhaled Medications Revenue by Type (2017-2028)
10.2 Middle East and Africa Devices for Inhaled Medications Market Size by Application
10.2.1 Middle East and Africa Devices for Inhaled Medications Sales by Application (2017-2028)
10.2.2 Middle East and Africa Devices for Inhaled Medications Revenue by Application (2017-2028)
10.3 Middle East and Africa Devices for Inhaled Medications Market Size by Country
10.3.1 Middle East and Africa Devices for Inhaled Medications Sales by Country (2017-2028)
10.3.2 Middle East and Africa Devices for Inhaled Medications Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Consort Medical
11.1.1 Consort Medical Corporation Information
11.1.2 Consort Medical Overview
11.1.3 Consort Medical Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Consort Medical Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Consort Medical Recent Developments
11.2 Inhalexper
11.2.1 Inhalexper Corporation Information
11.2.2 Inhalexper Overview
11.2.3 Inhalexper Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Inhalexper Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Inhalexper Recent Developments
11.3 Cambridge Consultants
11.3.1 Cambridge Consultants Corporation Information
11.3.2 Cambridge Consultants Overview
11.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cambridge Consultants Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cambridge Consultants Recent Developments
11.4 Hovione
11.4.1 Hovione Corporation Information
11.4.2 Hovione Overview
11.4.3 Hovione Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hovione Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hovione Recent Developments
11.5 Catalent, Inc
11.5.1 Catalent, Inc Corporation Information
11.5.2 Catalent, Inc Overview
11.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Catalent, Inc Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Catalent, Inc Recent Developments
11.6 VertMarkets, Inc
11.6.1 VertMarkets, Inc Corporation Information
11.6.2 VertMarkets, Inc Overview
11.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 VertMarkets, Inc Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 VertMarkets, Inc Recent Developments
11.7 Qualicaps
11.7.1 Qualicaps Corporation Information
11.7.2 Qualicaps Overview
11.7.3 Qualicaps Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Qualicaps Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Qualicaps Recent Developments
11.8 3M
11.8.1 3M Corporation Information
11.8.2 3M Overview
11.8.3 3M Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 3M Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 3M Recent Developments
11.9 Aerovance
11.9.1 Aerovance Corporation Information
11.9.2 Aerovance Overview
11.9.3 Aerovance Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Aerovance Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aerovance Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Corporation Information
11.11.2 Boehringer Ingelheim Overview
11.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Boehringer Ingelheim Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boehringer Ingelheim Recent Developments
11.12 Chiesi
11.12.1 Chiesi Corporation Information
11.12.2 Chiesi Overview
11.12.3 Chiesi Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Chiesi Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Chiesi Recent Developments
11.13 Cipla
11.13.1 Cipla Corporation Information
11.13.2 Cipla Overview
11.13.3 Cipla Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Cipla Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Cipla Recent Developments
11.14 Civitas/Alkermes
11.14.1 Civitas/Alkermes Corporation Information
11.14.2 Civitas/Alkermes Overview
11.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Civitas/Alkermes Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Civitas/Alkermes Recent Developments
11.15 GlaxoSmithKline
11.15.1 GlaxoSmithKline Corporation Information
11.15.2 GlaxoSmithKline Overview
11.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 GlaxoSmithKline Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 GlaxoSmithKline Recent Developments
11.16 Hovione
11.16.1 Hovione Corporation Information
11.16.2 Hovione Overview
11.16.3 Hovione Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Hovione Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Hovione Recent Developments
11.17 Mannkind
11.17.1 Mannkind Corporation Information
11.17.2 Mannkind Overview
11.17.3 Mannkind Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Mannkind Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Mannkind Recent Developments
11.18 Mantecorp
11.18.1 Mantecorp Corporation Information
11.18.2 Mantecorp Overview
11.18.3 Mantecorp Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Mantecorp Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Mantecorp Recent Developments
11.19 Meda
11.19.1 Meda Corporation Information
11.19.2 Meda Overview
11.19.3 Meda Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Meda Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Meda Recent Developments
11.20 MicroDose Therapeutx
11.20.1 MicroDose Therapeutx Corporation Information
11.20.2 MicroDose Therapeutx Overview
11.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 MicroDose Therapeutx Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 MicroDose Therapeutx Recent Developments
11.21 Novartis
11.21.1 Novartis Corporation Information
11.21.2 Novartis Overview
11.21.3 Novartis Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Novartis Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Devices for Inhaled Medications Industry Chain Analysis
12.2 Devices for Inhaled Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Devices for Inhaled Medications Production Mode & Process
12.4 Devices for Inhaled Medications Sales and Marketing
12.4.1 Devices for Inhaled Medications Sales Channels
12.4.2 Devices for Inhaled Medications Distributors
12.5 Devices for Inhaled Medications Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Devices for Inhaled Medications Industry Trends
13.2 Devices for Inhaled Medications Market Drivers
13.3 Devices for Inhaled Medications Market Challenges
13.4 Devices for Inhaled Medications Market Restraints
14 Key Findings in The Global Devices for Inhaled Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Devices for Inhaled Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Dry Powder Inhalers
Table 3. Major Manufacturers of Metered-Dose Inhalers
Table 4. Major Manufacturers of Nebulizers
Table 5. Major Manufacturers of Soft Mist Inhaler
Table 6. Global Devices for Inhaled Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Devices for Inhaled Medications Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Devices for Inhaled Medications Sales by Region (2017-2022) & (K Units)
Table 9. Global Devices for Inhaled Medications Sales Market Share by Region (2017-2022)
Table 10. Global Devices for Inhaled Medications Sales by Region (2023-2028) & (K Units)
Table 11. Global Devices for Inhaled Medications Sales Market Share by Region (2023-2028)
Table 12. Global Devices for Inhaled Medications Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Devices for Inhaled Medications Revenue Market Share by Region (2017-2022)
Table 14. Global Devices for Inhaled Medications Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Devices for Inhaled Medications Revenue Market Share by Region (2023-2028)
Table 16. Global Devices for Inhaled Medications Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Devices for Inhaled Medications Sales Share by Manufacturers (2017-2022)
Table 18. Global Devices for Inhaled Medications Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Devices for Inhaled Medications Revenue Share by Manufacturers (2017-2022)
Table 20. Devices for Inhaled Medications Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Devices for Inhaled Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Devices for Inhaled Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Devices for Inhaled Medications as of 2021)
Table 23. Devices for Inhaled Medications Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Devices for Inhaled Medications Product Offered
Table 25. Date of Manufacturers Enter into Devices for Inhaled Medications Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)
Table 28. Global Devices for Inhaled Medications Sales by Type (2023-2028) & (K Units)
Table 29. Global Devices for Inhaled Medications Sales Share by Type (2017-2022)
Table 30. Global Devices for Inhaled Medications Sales Share by Type (2023-2028)
Table 31. Global Devices for Inhaled Medications Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Devices for Inhaled Medications Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Devices for Inhaled Medications Revenue Share by Type (2017-2022)
Table 34. Global Devices for Inhaled Medications Revenue Share by Type (2023-2028)
Table 35. Devices for Inhaled Medications Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Devices for Inhaled Medications Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)
Table 38. Global Devices for Inhaled Medications Sales by Application (2023-2028) & (K Units)
Table 39. Global Devices for Inhaled Medications Sales Share by Application (2017-2022)
Table 40. Global Devices for Inhaled Medications Sales Share by Application (2023-2028)
Table 41. Global Devices for Inhaled Medications Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Devices for Inhaled Medications Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Devices for Inhaled Medications Revenue Share by Application (2017-2022)
Table 44. Global Devices for Inhaled Medications Revenue Share by Application (2023-2028)
Table 45. Devices for Inhaled Medications Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Devices for Inhaled Medications Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)
Table 48. North America Devices for Inhaled Medications Sales by Type (2023-2028) & (K Units)
Table 49. North America Devices for Inhaled Medications Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Devices for Inhaled Medications Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)
Table 52. North America Devices for Inhaled Medications Sales by Application (2023-2028) & (K Units)
Table 53. North America Devices for Inhaled Medications Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Devices for Inhaled Medications Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Devices for Inhaled Medications Sales by Country (2017-2022) & (K Units)
Table 56. North America Devices for Inhaled Medications Sales by Country (2023-2028) & (K Units)
Table 57. North America Devices for Inhaled Medications Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Devices for Inhaled Medications Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)
Table 60. Europe Devices for Inhaled Medications Sales by Type (2023-2028) & (K Units)
Table 61. Europe Devices for Inhaled Medications Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Devices for Inhaled Medications Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)
Table 64. Europe Devices for Inhaled Medications Sales by Application (2023-2028) & (K Units)
Table 65. Europe Devices for Inhaled Medications Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Devices for Inhaled Medications Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Devices for Inhaled Medications Sales by Country (2017-2022) & (K Units)
Table 68. Europe Devices for Inhaled Medications Sales by Country (2023-2028) & (K Units)
Table 69. Europe Devices for Inhaled Medications Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Devices for Inhaled Medications Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Devices for Inhaled Medications Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Devices for Inhaled Medications Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Devices for Inhaled Medications Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Devices for Inhaled Medications Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Devices for Inhaled Medications Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Devices for Inhaled Medications Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Devices for Inhaled Medications Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Devices for Inhaled Medications Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Devices for Inhaled Medications Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Devices for Inhaled Medications Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Devices for Inhaled Medications Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Devices for Inhaled Medications Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Devices for Inhaled Medications Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Devices for Inhaled Medications Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Devices for Inhaled Medications Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Devices for Inhaled Medications Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Devices for Inhaled Medications Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Devices for Inhaled Medications Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Devices for Inhaled Medications Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Devices for Inhaled Medications Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Devices for Inhaled Medications Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Devices for Inhaled Medications Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Devices for Inhaled Medications Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Devices for Inhaled Medications Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Devices for Inhaled Medications Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Devices for Inhaled Medications Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Devices for Inhaled Medications Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Devices for Inhaled Medications Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Devices for Inhaled Medications Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Devices for Inhaled Medications Revenue by Country (2023-2028) & (US$ Million)
Table 107. Consort Medical Corporation Information
Table 108. Consort Medical Description and Major Businesses
Table 109. Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Consort Medical Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Consort Medical Recent Developments
Table 112. Inhalexper Corporation Information
Table 113. Inhalexper Description and Major Businesses
Table 114. Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Inhalexper Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Inhalexper Recent Developments
Table 117. Cambridge Consultants Corporation Information
Table 118. Cambridge Consultants Description and Major Businesses
Table 119. Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Cambridge Consultants Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Cambridge Consultants Recent Developments
Table 122. Hovione Corporation Information
Table 123. Hovione Description and Major Businesses
Table 124. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Hovione Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Hovione Recent Developments
Table 127. Catalent, Inc Corporation Information
Table 128. Catalent, Inc Description and Major Businesses
Table 129. Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Catalent, Inc Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Catalent, Inc Recent Developments
Table 132. VertMarkets, Inc Corporation Information
Table 133. VertMarkets, Inc Description and Major Businesses
Table 134. VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. VertMarkets, Inc Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. VertMarkets, Inc Recent Developments
Table 137. Qualicaps Corporation Information
Table 138. Qualicaps Description and Major Businesses
Table 139. Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Qualicaps Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Qualicaps Recent Developments
Table 142. 3M Corporation Information
Table 143. 3M Description and Major Businesses
Table 144. 3M Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. 3M Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. 3M Recent Developments
Table 147. Aerovance Corporation Information
Table 148. Aerovance Description and Major Businesses
Table 149. Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Aerovance Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Aerovance Recent Developments
Table 152. AstraZeneca Corporation Information
Table 153. AstraZeneca Description and Major Businesses
Table 154. AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. AstraZeneca Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. AstraZeneca Recent Developments
Table 157. Boehringer Ingelheim Corporation Information
Table 158. Boehringer Ingelheim Description and Major Businesses
Table 159. Boehringer Ingelheim Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. Boehringer Ingelheim Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Boehringer Ingelheim Recent Developments
Table 162. Chiesi Corporation Information
Table 163. Chiesi Description and Major Businesses
Table 164. Chiesi Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Chiesi Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Chiesi Recent Developments
Table 167. Cipla Corporation Information
Table 168. Cipla Description and Major Businesses
Table 169. Cipla Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 170. Cipla Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Cipla Recent Developments
Table 172. Civitas/Alkermes Corporation Information
Table 173. Civitas/Alkermes Description and Major Businesses
Table 174. Civitas/Alkermes Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 175. Civitas/Alkermes Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Civitas/Alkermes Recent Developments
Table 177. GlaxoSmithKline Corporation Information
Table 178. GlaxoSmithKline Description and Major Businesses
Table 179. GlaxoSmithKline Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 180. GlaxoSmithKline Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. GlaxoSmithKline Recent Developments
Table 182. Hovione Corporation Information
Table 183. Hovione Description and Major Businesses
Table 184. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 185. Hovione Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Hovione Recent Developments
Table 187. Mannkind Corporation Information
Table 188. Mannkind Description and Major Businesses
Table 189. Mannkind Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 190. Mannkind Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Mannkind Recent Developments
Table 192. Mantecorp Corporation Information
Table 193. Mantecorp Description and Major Businesses
Table 194. Mantecorp Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 195. Mantecorp Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Mantecorp Recent Developments
Table 197. Meda Corporation Information
Table 198. Meda Description and Major Businesses
Table 199. Meda Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 200. Meda Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Meda Recent Developments
Table 202. MicroDose Therapeutx Corporation Information
Table 203. MicroDose Therapeutx Description and Major Businesses
Table 204. MicroDose Therapeutx Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 205. MicroDose Therapeutx Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. MicroDose Therapeutx Recent Developments
Table 207. Novartis Corporation Information
Table 208. Novartis Description and Major Businesses
Table 209. Novartis Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 210. Novartis Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Novartis Recent Developments
Table 212. Key Raw Materials Lists
Table 213. Raw Materials Key Suppliers Lists
Table 214. Devices for Inhaled Medications Distributors List
Table 215. Devices for Inhaled Medications Customers List
Table 216. Devices for Inhaled Medications Market Trends
Table 217. Devices for Inhaled Medications Market Drivers
Table 218. Devices for Inhaled Medications Market Challenges
Table 219. Devices for Inhaled Medications Market Restraints
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Devices for Inhaled Medications Product Picture
Figure 3. Global Devices for Inhaled Medications Market Share by Type in 2021 & 2028
Figure 3. Dry Powder Inhalers Product Picture
Figure 4. Metered-Dose Inhalers Product Picture
Figure 5. Nebulizers Product Picture
Figure 6. Soft Mist Inhaler Product Picture
Figure 7. Global Devices for Inhaled Medications Market Share by Application in 2021 & 2028
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Household
Figure 11. Devices for Inhaled Medications Report Years Considered
Figure 12. Global Devices for Inhaled Medications Sales 2017-2028 (K Units)
Figure 13. Global Devices for Inhaled Medications Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Devices for Inhaled Medications Revenue 2017-2028 (US$ Million)
Figure 15. Global Devices for Inhaled Medications Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Devices for Inhaled Medications Sales Market Share by Region (2017-2022)
Figure 17. Global Devices for Inhaled Medications Sales Market Share by Region (2023-2028)
Figure 18. North America Devices for Inhaled Medications Sales YoY (2017-2028) & (K Units)
Figure 19. North America Devices for Inhaled Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Devices for Inhaled Medications Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Devices for Inhaled Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Devices for Inhaled Medications Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Devices for Inhaled Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Devices for Inhaled Medications Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Devices for Inhaled Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Devices for Inhaled Medications Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Devices for Inhaled Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Devices for Inhaled Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Devices for Inhaled Medications in the World: Market Share by Devices for Inhaled Medications Revenue in 2021
Figure 30. Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Devices for Inhaled Medications Sales Market Share by Type (2017-2028)
Figure 32. Global Devices for Inhaled Medications Revenue Market Share by Type (2017-2028)
Figure 33. Global Devices for Inhaled Medications Sales Market Share by Application (2017-2028)
Figure 34. Global Devices for Inhaled Medications Revenue Market Share by Application (2017-2028)
Figure 35. North America Devices for Inhaled Medications Sales Market Share by Type (2017-2028)
Figure 36. North America Devices for Inhaled Medications Revenue Market Share by Type (2017-2028)
Figure 37. North America Devices for Inhaled Medications Sales Market Share by Application (2017-2028)
Figure 38. North America Devices for Inhaled Medications Revenue Market Share by Application (2017-2028)
Figure 39. North America Devices for Inhaled Medications Sales Share by Country (2017-2028)
Figure 40. North America Devices for Inhaled Medications Revenue Share by Country (2017-2028)
Figure 41. U.S. Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Devices for Inhaled Medications Sales Market Share by Type (2017-2028)
Figure 44. Europe Devices for Inhaled Medications Revenue Market Share by Type (2017-2028)
Figure 45. Europe Devices for Inhaled Medications Sales Market Share by Application (2017-2028)
Figure 46. Europe Devices for Inhaled Medications Revenue Market Share by Application (2017-2028)
Figure 47. Europe Devices for Inhaled Medications Sales Share by Country (2017-2028)
Figure 48. Europe Devices for Inhaled Medications Revenue Share by Country (2017-2028)
Figure 49. Germany Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 50. France Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Devices for Inhaled Medications Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Devices for Inhaled Medications Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Devices for Inhaled Medications Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Devices for Inhaled Medications Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Devices for Inhaled Medications Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Devices for Inhaled Medications Revenue Share by Region (2017-2028)
Figure 60. China Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 63. India Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Devices for Inhaled Medications Sales Market Share by Type (2017-2028)
Figure 71. Latin America Devices for Inhaled Medications Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Devices for Inhaled Medications Sales Market Share by Application (2017-2028)
Figure 73. Latin America Devices for Inhaled Medications Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Devices for Inhaled Medications Sales Share by Country (2017-2028)
Figure 75. Latin America Devices for Inhaled Medications Revenue Share by Country (2017-2028)
Figure 76. Mexico Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Devices for Inhaled Medications Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Devices for Inhaled Medications Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Devices for Inhaled Medications Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Devices for Inhaled Medications Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Devices for Inhaled Medications Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Devices for Inhaled Medications Revenue Share by Country (2017-2028)
Figure 85. Turkey Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Devices for Inhaled Medications Revenue (2017-2028) & (US$ Million)
Figure 88. Devices for Inhaled Medications Value Chain
Figure 89. Devices for Inhaled Medications Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Industry Market Size
